Dr Llewellyn Fleurs obtained his BSc (Biochemistry) in 1990 and his MBChB in 1997, both from the University of Cape Town. He completed his internship at King Edward VIII Hospital in 1998, and his community service at Groote Schuur Hospital in 1999. From 2000 – 2002, he worked for the Department of Health at Lotus River Day Hospital. He then joined Prime Cure Mediclinic in 2003 where he worked as part of a medical team comprising himself and 2 clinical nurse practitioners, and performed his first clinical trial involving a buccal medication for oral candidiasis in HIV positive patients. He has worked for the DTHF since 2004, and has worked at Emavundleni as a sub-investigator since 2006.. He has been involved in several HIV vaccine, microbicide and pre-exposure prophylaxis clinical trials. He has also worked on HPV vaccine trials, seroconverter and vaccine-induced seropositivity protocols, and been involved in source document development. He has also been a co-author on a research paper on circumcision and HIV, and is currently in his final year of Masters in Public Health.